ASCO Adds MammaPrint to Breast Cancer Guideline
Medscape,
In an update to its 2016 clinical practice guideline on the use of biomarkers in early invasive breast cancer, the American…
In an update to its 2016 clinical practice guideline on the use of biomarkers in early invasive breast cancer, the American…
Women who have clinically high-risk, hormone receptor (HR)-positive, HER2-negative breast cancer may use results of the…
Here are what the editors at HealthDay consider to be the most important developments in Pathology for February 2016.
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for February 2016.